{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:16:45Z","timestamp":1776734205973,"version":"3.51.2"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Michael Smith Foundation"},{"DOI":"10.13039\/100005622","name":"Health Research","doi-asserted-by":"publisher","award":["377364"],"award-info":[{"award-number":["377364"]}],"id":[{"id":"10.13039\/100005622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1053\/j.ajkd.2018.07.014","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T01:34:41Z","timestamp":1538098481000},"page":"39-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis"],"prefix":"10.1053","volume":"73","author":[{"given":"Jonathon R.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Ronald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Sadatsafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Balshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2018.07.014_bib1","series-title":"The Top 10 Causes of Death","year":"2017"},{"key":"10.1053\/j.ajkd.2018.07.014_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","article-title":"The impact of migration on tuberculosis epidemiology and control\u00a0in high-income countries: a review","volume":"14","author":"Pareek","year":"2016","journal-title":"BMC Med"},{"issue":"4","key":"10.1053\/j.ajkd.2018.07.014_bib3","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1053\/j.ajkd.2018.07.014_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1503\/cmaj.131025","article-title":"Screening immigrants for latent tuberculosis: do we have the resources?","volume":"186","author":"Campbell","year":"2014","journal-title":"CMAJ"},{"issue":"10","key":"10.1053\/j.ajkd.2018.07.014_bib5","doi-asserted-by":"crossref","first-page":"e0186778","DOI":"10.1371\/journal.pone.0186778","article-title":"Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada","volume":"12","author":"Campbell","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2018.07.014_bib6","series-title":"Latent TB Infection: Updated and Consolidated Guidelines for Programmatic Management","year":"2018"},{"key":"10.1053\/j.ajkd.2018.07.014_bib7","series-title":"Canadian Tuberculosis Standards","year":"2014"},{"key":"10.1053\/j.ajkd.2018.07.014_bib8","series-title":"Latent Tuberculosis Infection: A Guide for Primary Health Care Providers","year":"2013"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1525-139X.2003.03010.x","article-title":"Tuberculosis and chronic renal disease","volume":"16","author":"Hussein","year":"2003","journal-title":"Semin Dial"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","article-title":"Tuberculosis and chronic kidney disease: an emerging global syndemic","volume":"90","author":"Romanowski","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2018.07.014_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5414\/CNP59436","article-title":"Tuberculosis screening in dialysis patients--is the tuberculin test effective?","volume":"59","author":"Poduval","year":"2003","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","article-title":"Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection","volume":"28","author":"Lee","year":"2006","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1053\/j.ajkd.2018.07.014_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-139X.2010.00784.x","article-title":"Inflammation in end-stage renal disease--what have we learned in 10 years?","volume":"23","author":"Carrero","year":"2010","journal-title":"Semin Dial"},{"issue":"9456","key":"10.1053\/j.ajkd.2018.07.014_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"Meguid El Nahas","year":"2005","journal-title":"Lancet"},{"issue":"9981","key":"10.1053\/j.ajkd.2018.07.014_bib15","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.ajkd.2018.07.014_bib16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.5588\/ijtld.15.0825","article-title":"Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis","volume":"20","author":"Campbell","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2018.07.014_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfs479","article-title":"Cost effectiveness of the interferon-\u03b3 release assay for tuberculosis screening of hemodialysis patients","volume":"28","author":"Kowada","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2018.07.014_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1053\/j.ajkd.2018.07.014_bib19","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.ajkd.2018.07.014_bib20","unstructured":"Population Data BC. Population data BC. Published 2017. https:\/\/www.popdata.bc.ca\/. Accessed August 13,\u00a02017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib21","unstructured":"BC Renal Agency. BC Provincial Renal Agency Database (PROMIS). Population Data BC; 2015 Data Extract. PROMIS (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib22","unstructured":"Immigration, Refugees, and Citizenship Canada. Population Data BC; 2015 Data Extract. IRCC (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib23","unstructured":"BC Centre for Disease Control. BC Provincial HIV\/AIDS Surveillance Database (BCCDC-HAISIS). Population Data BC; 2015. Data Extract. BCCDC (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib24","unstructured":"BC Centre for Disease Control. BC Provincial TB Registry (BCCDC-iPHIS). Population Data BC; 2015. Data Extract. BCCDC (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib25","unstructured":"BC Ministry of Health. PharmaNet. BC Ministry of Health; 2015. Data Extract. Data Stewardship Committee (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib26","unstructured":"BC Vital Statistics Agency. BC Vital Statistics. Population Data\u00a0BC; 2015. Data Extract. BC Vital Statistics Agency (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib27","unstructured":"British Columbia Ministry of Health. Consolidation File (MSP Registration & Premium Billing). Population Data BC; 2015. Data Extract. MOH (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib28","unstructured":"British Columbia Ministry of Health. Medical Service Plan (MSP) Payment Information File. Population Data BC; 2015. Data Extract. MOH (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"key":"10.1053\/j.ajkd.2018.07.014_bib29","unstructured":"Canadian Institute for Health Information. Discharge Abstract Database (Hospital Separations). Population Data BC; 2015. Data Extract. MOH (2014). http:\/\/www.popdata.bc.ca\/data. Accessed August 13, 2017."},{"issue":"11","key":"10.1053\/j.ajkd.2018.07.014_bib30","doi-asserted-by":"crossref","first-page":"e013488","DOI":"10.1136\/bmjopen-2016-013488","article-title":"Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study","volume":"6","author":"Ronald","year":"2016","journal-title":"BMJ Open"},{"issue":"6","key":"10.1053\/j.ajkd.2018.07.014_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jval.2012.04.013","article-title":"Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4","volume":"15","author":"Karnon","year":"2012","journal-title":"Value Health"},{"key":"10.1053\/j.ajkd.2018.07.014_bib32","series-title":"Guidelines for the Economic Evaluation of Health Technologies: Canada","year":"2017"},{"issue":"8","key":"10.1053\/j.ajkd.2018.07.014_bib33","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.144.8.1667","article-title":"Rifampin drug interactions","volume":"144","author":"Baciewicz","year":"1984","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2018.07.014_bib34","first-page":"1","article-title":"A\u00a0review of rifapentine for treating active and latent tuberculosis","volume":"5","author":"Haas","year":"2015","journal-title":"Clin Invest Lond"},{"issue":"2","key":"10.1053\/j.ajkd.2018.07.014_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40291-015-0135-6","article-title":"Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis","volume":"19","author":"Campbell","year":"2015","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"10.1053\/j.ajkd.2018.07.014_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2018.07.014_bib37","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","article-title":"Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection","volume":"179","author":"Holland","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1053\/j.ajkd.2018.07.014_bib38","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","author":"Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2018.07.014_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF03405248","article-title":"Costs for tuberculosis care in Canada","volume":"99","author":"Menzies","year":"2008","journal-title":"Can J Public Health"},{"issue":"2","key":"10.1053\/j.ajkd.2018.07.014_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1524-4733.2008.00433.x","article-title":"Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 preference-based SF-6D in chronic kidney disease","volume":"12","author":"Davison","year":"2009","journal-title":"Value Health"},{"issue":"9","key":"10.1053\/j.ajkd.2018.07.014_bib41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10198-014-0664-7","article-title":"Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD)","volume":"16","author":"Yang","year":"2015","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5539\/gjhs.v3n1p203","article-title":"Measurement of SF-6D utility among patients with active tuberculosis","volume":"3","author":"Awan","year":"2011","journal-title":"Global J Health Sci"},{"issue":"6","key":"10.1053\/j.ajkd.2018.07.014_bib43","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11136-014-0858-6","article-title":"The impact of tuberculosis on health utility: a longitudinal cohort study","volume":"24","author":"Bauer","year":"2015","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1053\/j.ajkd.2018.07.014_bib44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08860220903367528","article-title":"Incidence of tuberculosis disease\u00a0and latent tuberculosis infection in patients with end stage renal disease in an endemic region","volume":"32","author":"Ates","year":"2010","journal-title":"Ren Fail"},{"issue":"7","key":"10.1053\/j.ajkd.2018.07.014_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1469-0691.2009.02949.x","article-title":"Validity of interferon-\u03b3-release assays for the diagnosis of latent tuberculosis in haemodialysis patients","volume":"16","author":"Chung","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"04","key":"10.1053\/j.ajkd.2018.07.014_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4236\/ojneph.2015.54017","article-title":"Tuberculosis among chronic hemodialysis patients: a Senegalese single center experience","volume":"05","author":"Cisse","year":"2015","journal-title":"Open J Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2018.07.014_bib48","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/ndt\/gfp030","article-title":"The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients","volume":"24","author":"Inoue","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2018.07.014_bib49","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/ndt\/gfp224","article-title":"Diagnosis of pulmonary tuberculosis among dialysis patients by enzyme-linked immunospot assay for\u00a0interferon-\u03b3","volume":"24","author":"Lai","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2018.07.014_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3855\/jidc.2664","article-title":"Tuberculosis in dialysis patients: a nine-year retrospective analysis","volume":"7","author":"Unsal","year":"2013","journal-title":"J\u00a0Infect Dev Ctries"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40291-014-0125-0","article-title":"A\u00a0systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants","volume":"19","author":"Campbell","year":"2015","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"10.1053\/j.ajkd.2018.07.014_bib52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2018.07.014_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2018.07.014_bib54","first-page":"S599","article-title":"Latent tuberculosis treatment cascade in chronic kidney disease patients: the Vancouver experience","volume":"3","author":"Harris","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.ajkd.2018.07.014_bib55","unstructured":"Badar S, Ara\u00fajo T, Zwerling A, Pai M. BCG World Atlas. Published 2017. http:\/\/www.bcgatlas.org\/index.php. Accessed March 7,\u00a02018."},{"key":"10.1053\/j.ajkd.2018.07.014_bib56","series-title":"WHO-UNICEF Estimates of BCG Coverage","year":"2017"},{"issue":"12","key":"10.1053\/j.ajkd.2018.07.014_bib57","doi-asserted-by":"crossref","first-page":"e29563","DOI":"10.1371\/journal.pone.0029563","article-title":"Risk of tuberculosis in dialysis patients: a nationwide cohort study","volume":"6","author":"Dobler","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2018.07.014_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5414\/CNP67217","article-title":"Tuberculosis in chronic kidney disease","volume":"67","author":"Venkata","year":"2007","journal-title":"Clin Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2018.07.014_bib59","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/ndt\/gfl488","article-title":"Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients","volume":"21","author":"Klote","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2018.07.014_bib60","article-title":"Dialysis patients with\u00a0tuberculosis","volume":"161","author":"FitzGerald","year":"1999","journal-title":"Can Med Assoc J"},{"issue":"8","key":"10.1053\/j.ajkd.2018.07.014_bib61","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1503\/cmaj.170817","article-title":"Demographic predictors of active tuberculosis in people migrating to British Columbia, Canada: a retrospective cohort study","volume":"190","author":"Ronald","year":"2018","journal-title":"CMAJ"},{"key":"10.1053\/j.ajkd.2018.07.014_bib62","unstructured":"Canadian Institute for Health Information. Patient cost estimator. Published 2017. https:\/\/www.cihi.ca\/en\/patient-cost-estimator. Accessed August 10,\u00a02017."},{"issue":"7143","key":"10.1053\/j.ajkd.2018.07.014_bib63","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.316.7143.1529","article-title":"Perspectives in economic evaluation","volume":"316","author":"Byford","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"10.1053\/j.ajkd.2018.07.014_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpainsymman.2009.04.007","article-title":"Cost trajectories at the end of life: the Canadian experience","volume":"38","author":"Fassbender","year":"2009","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"6","key":"10.1053\/j.ajkd.2018.07.014_bib65","first-page":"711","article-title":"Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada","volume":"8","author":"Levesque","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2018.07.014_bib66","first-page":"560","article-title":"Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis","volume":"159","author":"Salpeter","year":"1993","journal-title":"West J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618308783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618308783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:03:19Z","timestamp":1759460599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618308783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0272638618308783"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.07.014","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}